Lung - Refresher 2022
Lung - Refresher 2022 is organized by American Society for Radiation Oncology (ASTRO).
Course opens: 05/02/2022
Course expires: 05/01/2025
Description :
Major decreases in cancer mortality have been driven by improvements in the management of lung cancer. The explanation for these survival improvements is complex but largely driven by the increasing use of systemic therapies in early-stage diseases such as immunotherapy. Additionally, local ablative therapies in advanced-stage disease are also improving outcomes. Translation of these practices into a community-based setting is important. This educational activity will help participants to better apply new treatment strategies so that patient outcomes can be enhanced. Additionally, it will provide insight into where current deficits in management remain and future studies to answer these questions.
Learning Objectives :
Upon completion of this activity, learners should be able to:
• Explain the increasing use of immunotherapy for non-metastatic lung cancer.
• Apply principles of when radiotherapy is appropriate (and when it is not) in advanced lung cancer.
• Explore the evolving treatment options for locally advanced, resectable lung cancer.
Additional details will be posted as soon as information is available.